Short Interest in HCW Biologics Inc. (NASDAQ:HCWB) Increases By 905.4%

HCW Biologics Inc. (NASDAQ:HCWB) saw a significant growth in short interest in February. As of February 15th, there was short interest totalling 835,500 shares, a growth of 905.4% from the January 31st total of 83,100 shares. Based on an average daily trading volume, of 6,100,000 shares, the short-interest ratio is presently 0.1 days. Currently, 3.6% of the company’s stock are sold short.

HCW Biologics Trading Up 2.7 %

Shares of NASDAQ:HCWB traded up $0.01 during trading on Thursday, reaching $0.38. The stock had a trading volume of 83,568 shares, compared to its average volume of 9,739,002. The firm’s 50-day simple moving average is $0.39 and its 200 day simple moving average is $0.47. HCW Biologics has a one year low of $0.21 and a one year high of $2.52. The company has a market capitalization of $16.70 million, a P/E ratio of -0.38 and a beta of 0.81.

HCW Biologics Company Profile

HCW Biologics Inc, a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, which is in Phase 1 clinical chemo-refractory/chemo-resistant solid tumors with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as Phase 2 clinical trial with metastatic advanced stage ovarian cancer patients; and HCW9302 for autoimmune and proinflammatory diseases, such as alopecia areata diseases.